TransLucent has begun the process of taking legal action against the Equality and Human Rights Commission (EHRC), alleging that the EHRC is acting unlawfully in response to a Supreme Court judgment on trans people under the Equality Act by proposing an inadequately short two-week consultation and holding a predetermined view on how to update its statutory guidance, a belief reinforced by public statements from senior EHRC personnel. Continue Reading TransLucent has begun the process of taking legal action against the Equality and Human Rights Commission (EHRC).
TransLucent’s position statement argues against the ban on puberty blockers (GnRH analogues) for young trans people, citing insufficient evidence and potential bias in the Cass Review. Continue Reading TransLucent Puberty Blocker (GnRH Analogues) Position Statement
The TransLucent briefing notes are for MPs and journalists, giving details on human rights issues facing the trans community, a marginalised and vulnerable demographic.
Continue Reading Briefing Notes For MPs and Media
The briefing note addresses claims about trans women in female NHS hospital wards, concluding that allowing trans women to occupy a bed in a ward aligning with their gender identity is a matter of equality and non-discrimination. Investigations found no serious complaints regarding trans women inpatients in female NHS hospital wards.
Continue Reading Trans Women in Female NHS Hospital Wards
The Cass Review briefing note examines the Cass Review’s recommendations for gender identity services. TransLucent’s report identifies concerns from service users, professionals, and human rights organisations, and offers solutions. Continue Reading The Cass Review – Briefing Note
Organised transphobia uses strategies like othering, moral panics, and populist discourse to undermine trans rights. These tactics involve portraying trans people as a threat to society, thereby justifying discrimination. Continue Reading Strategies in Organised Transphobia – Briefing Note
The aim of this survey was to ascertain if there were major problems with Transgender Women using Changing/Locker Rooms and Toilets within the Local Authority owned estate.
The Society for Evidence Based Gender Medicine, described by researchers as a small group of anti-trans activists and a named hate group, influenced UK gender-affirming healthcare via the Cass Review. Continue Reading Exposing SEGM’s Influence on UK Trans Healthcare & Cass Review
The Lemkin Institute has issued a “Red Alert for Genocide” for the UK trans and intersex community due to concerning governmental and judicial actions. Continue Reading Genocide Warning Issued for UK Trans Community
A new research paper reveals severe adverse effects including declining mental health, increased depression, self-harm, and suicide ideation among trans and non-binary young people and their parents following the UK puberty blocker ban Continue Reading The UK Puberty Blocker Ban: Evidence Reveals Widespread Harm to Transgender Children
TransLucent expresses profound concern to the Scottish Government, urging it to resist Sex Matters’ regressive demands for single-sex spaces based on ‘biological sex’ and instead reaffirm its commitment to transgender human rights. Continue Reading Our Letter to the Scottish Government – Transgender Rights & Single Sex Spaces
The EHRC’s proposed guidance is an unlawful and harmful attempt to redefine sex and exclude trans people, violating legal frameworks and international human rights Continue Reading A Catastrophe in Slow Motion: Why the EHRC’s Guidance Must Be Stopped Now
An altercation at a WESC meeting demonstrates the significant distress and legal challenges faced by transgender individuals following the Supreme Court judgment, prompting calls for urgent parliamentary action. Continue Reading Parliamentary Altercation Highlights Crisis in Trans Rights Post-SC Judgment
The “Not In Our Name” Women’s Collective represents a group of cisgender women rejecting anti-trans discrimination and stating the real threat to women is male violence, and not trans people.
Coming soon! Subscribe now to recieve the latest news from TransLucent.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
